Magnesium Supplements Failed to Improve Arterial Health in Type 2 Diabetes Study

Arterial stiffness and calcium buildup in blood vessels significantly increase cardiovascular disease risk in people with type 2 diabetes, making interventions to protect arterial health crucial for longevity. This study tested whether magnesium supplementation could address these issues.

Researchers conducted a six-month randomized, double-blind, placebo-controlled trial with 74 older adults (average age 72) who had type 2 diabetes, arterial calcification, and elevated arterial stiffness. Participants received either 350mg daily magnesium citrate or placebo while researchers measured arterial stiffness and blood markers of calcification.

The results were disappointing: magnesium supplementation provided no cardiovascular benefits. Despite successfully increasing magnesium excretion in urine, supplements failed to raise blood magnesium levels or improve arterial health markers. Arterial stiffness actually appeared to worsen slightly in the magnesium group, though this effect disappeared after accounting for baseline differences between groups.

For longevity-focused individuals, these findings suggest that magnesium supplementation alone may not protect against cardiovascular aging in people with diabetes who already have adequate magnesium status. The lack of benefit likely occurred because participants had normal magnesium levels and healthy kidney function at baseline. This highlights the importance of addressing magnesium deficiency rather than supplementing when levels are already sufficient. The study reinforces that cardiovascular protection in diabetes requires comprehensive approaches beyond single-nutrient supplementation, including blood sugar control, exercise, and proven cardiovascular medications.